Anthony G. Quinn
2022
In 2022, Anthony G. Quinn earned a total compensation of $2.4M as Former President and Chief Executive Officer at Aeglea BioTherapeutics, a 9% decrease compared to previous year.
Compensation breakdown
| Option Awards | $779,625 |
|---|---|
| Salary | $424,429 |
| Other | $1,188,200 |
| Total | $2,392,254 |
Quinn received $1.2M in other compensation, accounting for 50% of the total pay in 2022.
Quinn also received $779.6K in option awards and $424.4K in salary.
Rankings
In 2022, Anthony G. Quinn's compensation ranked 1,505th out of 5,542 executives tracked by ExecPay. In other words, Quinn earned more than 72.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,505 out of 5,542 | 73rd |
Division Manufacturing | 756 out of 3,000 | 75th |
Major group Chemicals And Allied Products | 292 out of 1,350 | 78th |
Industry group Drugs | 270 out of 1,253 | 79th |
Industry Pharmaceutical Preparations | 192 out of 907 | 79th |
Source: SEC filing on October 26, 2023.
Quinn's colleagues
We found four more compensation records of executives who worked with Anthony G. Quinn at Aeglea BioTherapeutics in 2022.
News
Aeglea BioTherapeutics CEO Anthony Quinn's 2022 pay slips 9% to $2.4M
April 17, 2023
Aeglea BioTherapeutics CEO Anthony Quinn's 2021 pay slips 10% to $2.6M
April 21, 2022
Aeglea BioTherapeutics CEO Anthony Quinn's 2019 pay falls 35% to $2.5M
April 23, 2020
Aeglea BioTherapeutics CEO Anthony Quinn's 2018 pay jumps 274% to $3.8M
April 22, 2019